Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model.

[1]  H. Genant,et al.  Teriparatide for acceleration of fracture repair in humans: A prospective, randomized, double‐blind study of 102 postmenopausal women with distal radial fractures , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  Meng-ning Yan,et al.  Reconstruction of peri-implant bone defects using impacted bone allograft and BMP-2 gene-modified bone marrow stromal cells. , 2009, Journal of biomedical materials research. Part A.

[3]  H. Mankin,et al.  The current state of limb salvage surgery , 2009, Skeletal Radiology.

[4]  M. O. Papuga,et al.  μCT‐Based Measurement of Cortical Bone Graft‐to‐Host Union , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  A. Geiser,et al.  Longitudinal in vivo analysis of the region-specific efficacy of parathyroid hormone in a rat cortical defect model. , 2009, Endocrinology.

[6]  S. Goldstein,et al.  Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation. , 2008, Bone.

[7]  S. Kakar,et al.  Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. , 2008, The Journal of bone and joint surgery. American volume.

[8]  S. Kakar,et al.  Enhanced Chondrogenesis and Wnt Signaling in PTH‐Treated Fractures , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  A. Minami,et al.  Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1-34) in a rat spinal arthrodesis model. , 2007, Bone.

[10]  Robert E Guldberg,et al.  Recent advances in gene delivery for structural bone allografts. , 2007, Tissue engineering.

[11]  M. Swiontkowski,et al.  Health-care costs associated with amputation or reconstruction of a limb-threatening injury. , 2007, The Journal of bone and joint surgery. American volume.

[12]  Hiroshi Tanaka,et al.  Sequential Treatment with Intermittent Low-Dose Human Parathyroid Hormone (1-34) and Bisphosphonate Enhances Large-Size Skeletal Reconstruction by Vascularized Bone Transplantation , 2007, Calcified Tissue International.

[13]  Tetsuji Yamamoto,et al.  Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys. , 2007, Bone.

[14]  M. Swiontkowski,et al.  Complex Limb Salvage or Early Amputation for Severe Lower-Limb Injury: A Meta-Analysis of Observational Studies , 2007, Journal of orthopaedic trauma.

[15]  R. Guldberg,et al.  Structural bone allograft combined with genetically engineered mesenchymal stem cells as a novel platform for bone tissue engineering. , 2006, Tissue engineering.

[16]  S. Mirza,et al.  Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. , 2006, The Journal of bone and joint surgery. American volume.

[17]  T. Einhorn,et al.  Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing. , 2005, Bone.

[18]  R. Guldberg,et al.  Biological effects of rAAV-caAlk2 coating on structural allograft healing. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  S. Goldstein,et al.  Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone. , 2005, Bone.

[20]  W. Enneking,et al.  Allograft Bone Decreases in Strength In Vivo over Time , 2005, Clinical orthopaedics and related research.

[21]  B. Mitlak,et al.  Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). , 2005, The Journal of bone and joint surgery. American volume.

[22]  S. Komatsubara,et al.  Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. , 2005, Bone.

[23]  L. Sangiorgi,et al.  Stromal Stem Cells and Platelet-Rich Plasma Improve Bone Allograft Integration , 2005, Clinical orthopaedics and related research.

[24]  Hiromu Ito,et al.  Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy , 2005, Nature Medicine.

[25]  E. Schwarz,et al.  A novel murine segmental femoral graft model , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[26]  B. Brigman,et al.  Allografts about the Knee in Young Patients with High-Grade Sarcoma , 2004, Clinical orthopaedics and related research.

[27]  J. F. Whitfield,et al.  Treatment with Parathyroid Hormone hPTH(1-34), hPTH(1-31), and Monocyclic hPTH(1-31) Enhances Fracture Strength and Callus Amount After Withdrawal Fracture Strength and Callus Mechanical Quality Continue to Increase , 2004, Calcified Tissue International.

[28]  S. Goldstein,et al.  Combination of Local and Systemic Parathyroid Hormone Enhances Bone Regeneration , 2003, Clinical orthopaedics and related research.

[29]  James F Kellam,et al.  An analysis of outcomes of reconstruction or amputation after leg-threatening injuries. , 2002, The New England journal of medicine.

[30]  T. Einhorn,et al.  Mechanisms for the Enhancement of Fracture Healing in Rats Treated With Intermittent Low‐Dose Human Parathyroid Hormone (1–34) , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  J. Jahng,et al.  Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats. , 2000, The Iowa orthopaedic journal.

[32]  P. Roberson,et al.  Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. , 1999, The Journal of clinical investigation.

[33]  Jeffrey Bonadio,et al.  Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration , 1999, Nature Medicine.

[34]  R. Turner,et al.  Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats. , 1995, Endocrinology.

[35]  R. Turner,et al.  Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. , 1995, Endocrinology.

[36]  M. Gebhardt,et al.  Fractures of allografts. Frequency, treatment, and end-results. , 1990, The Journal of bone and joint surgery. American volume.

[37]  J. Potts,et al.  Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients. , 1981, The Journal of clinical investigation.

[38]  J Reeve,et al.  Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. , 1980, British medical journal.

[39]  P. Scherer,et al.  Accelerated fracture healing. , 1976, Journal of the American Podiatry Association.

[40]  E. Schwarz,et al.  Orthopaedic war injuries: from combat casualty care to definitive treatment: a current review of clinical advances, basic science, and research opportunities. , 2008, Instructional course lectures.

[41]  M. Swiontkowski.  Health-Care Costs Associated with Amputation or Reconstruction of a Limb-Threatening Injury , 2008 .

[42]  Amy L Lerner,et al.  Micro-computed tomography prediction of biomechanical strength in murine structural bone grafts. , 2007, Journal of biomechanics.

[43]  P. Meunier,et al.  Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy. , 1981, Metabolic bone disease & related research.

[44]  T. Liu,et al.  Transplantation of preserved composite tendon allografts. , 1975, The Journal of bone and joint surgery. American volume.